Jeena Sikho Lifecare Ltd
📊 Quarterly Financial & Operational Performance Update
⚡️ Quick Scoop
- Reported Q3 FY26 revenue ₹221.66 crore, 92% YoY growth - EBITDA at ₹100.80 crore with 45% margin - PAT ₹66.73 crore, up 405% YoY - 475+ beds under development enhancing capacity - Strong growth in patient volumes, innovative product launches
🧠💡DeepDive
📊 Quarterly Financial & Operational Performance Update
🔍 Quarterly Financial Highlights:
- Revenue: Increased 92% YoY to ₹221.66 crore in Q3 FY26.
- EBITDA: ₹100.80 crore with 45% margin, indicating operational efficiency.
- PAT: Rose 405% YoY to ₹66.73 crore, showing strong profitability.
- 9MFY26: 78% revenue growth YoY, EBITDA margin up to 46% from 29% in FY25, showing scaling benefits.
🏥 Operational Growth:
- Growth in patient volumes across outpatient, inpatient, day care, and video consultations.
- Over 475 beds under development, indicating capacity expansion and future volume growth.
🛍 Product & Market Developments:
- Ayurveda healthcare product segment gaining momentum with new and existing products.
- Launch planned for "Jeena Sikho Health Card" offering customer value and convenience.
- Rising nationwide acceptance of Ayurvedic healthcare supports growth.
🔮 Investor Insights:
- Strong financials and capacity additions suggest growing business scale.
- Strategic innovation and product diversification may sustain growth long term.
This update provides key financial and strategic details, which may be helpful for investors wanting to understand company progress and outlook.
